iGene Laboratory
iGene Laboratory is a Singapore-based, CAP-accredited and MOH-licensed clinical molecular diagnostics laboratory serving clinicians, patients, and CROs across South East Asia with pre-conception, pre-natal, and women's health genetic and molecular testing services.
- Company typePrivate
- Founded2014
- HeadquartersSingapore, Singapore
- Headcount51–100
- GTM typeB2B
- OfferingServices
What iGene Laboratory does
iGene Laboratory Private Limited is a Singapore-based clinical molecular diagnostics laboratory established in 2014 and operating as a wholly-owned subsidiary of INEX Innovate Pte Ltd. The company is licensed by the Singapore Ministry of Health (MOH) and accredited by the College of American Pathologists (CAP) in Next Generation Sequencing (NGS) and Molecular Microbiology, including COVID-19 testing (CAP Number: 8124837; HCI Number: 17I0382). It operates as a Tier 3 laboratory with automatic results submission to Singapore's National Electronic Health Record (NEHR), and is PDPA compliant.
The laboratory offers an integrated portfolio organized across three clinical categories: pre-conception testing (ora™ Test, CarrierGene™, HPV HR14 mRNA test, STI-7 panel), pre-natal testing (iGene® NIPT, SingGene NIPT, Fetal DNA Chip v2.0, Fetal Seq v1.0, Fetal Exome covering protein-coding regions of over 20,000 annotated genes), and women's health / immunology and serology services (Preeclampsia Screening via PlGF). Underlying technology is built on CAP-accredited Next Generation Sequencing and molecular microbiology workflows, with specialized molecular assays such as HPV mRNA testing targeting E6/E7 transcripts and a multiplexed STI-7 panel detecting six infections from a single vaginal swab.
iGene generates revenue primarily through fee-for-service genetic and molecular testing sold to medical professionals, clinics, and patients across the South East Asian region, with a secondary revenue stream from clinical molecular testing services provided to Contract Research Organizations. Pricing is quote-based and not publicly disclosed, with multi-year contractual arrangements typically negotiated through the commercial team. The go-to-market is sales-led, with direct B2B relationships with clinicians supplemented by distributor and CRO partnership channels, supported by a dedicated clinic portal (report.igenelab.com) and a dedicated lab hotline. The company employed 51-100 people as of the data window and has no disclosed funding history or revenue figures.
iGene Laboratory firmographics
Firmographics- Name
- iGene Laboratory
- Legal name
- iGene Laboratory Private Limited
- Website
- https://igenelab.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- iGene Laboratory is a Singapore-based, CAP-accredited and MOH-licensed clinical molecular diagnostics laboratory serving clinicians, patients, and CROs across South East Asia with pre-conception, pre-natal, and women's health genetic and molecular testing services.
- Ownership category
- akta.pro rank
iGene Laboratory industry classification
Industry- Product category
- Clinical Molecular Diagnostics Laboratory Services
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Genetic & Prenatal Testing Laboratories (HLAFAMAH)
- akta.pro secondary industries
- Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ), Molecular Diagnostics & Genomics Laboratories (HLAFAMAE), Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD), Genetic, Cytogenetic & Prenatal Screening IVD (HLAHAAAI)
Keywords
Where iGene Laboratory is headquartered
LocationHeadquarters
- HQ city
- Singapore
- HQ country
- Singapore
- HQ region
- Asia
Offices1 record
Markets served
iGene Laboratory business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales
Revenue model
- Genetic Testing Services: Clinical laboratory services providing genetic testing including pre-conception, pre-natal, women's health, and molecular diagnostics services to medical professionals and patients
- Clinical Research Services (CRO): Clinical research services provided to Contract Research Organizations in the area of clinical molecular testing
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Laboratory diagnostic testing services |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
iGene Laboratory product offering
Product offeringCore offering
iGene Laboratory operates a CAP-accredited clinical molecular diagnostics laboratory in Singapore, providing genetic testing, molecular microbiology, immunology, and serology services. Its portfolio covers pre-conception screening (ora™ Test, CarrierGene™), prenatal diagnostics (NIPT, Fetal DNA Chip, Fetal Seq, Fetal Exome), and women's health tests (HPV HR14, STI-7, Preeclampsia/PlGF Screening) for clinicians, clinics, and CROs.
Product overview
iGene Laboratory is a clinical molecular diagnostics laboratory established in 2014 as a wholly-owned subsidiary of INEX Innovate Pte Ltd, based in Singapore. The company provides a comprehensive portfolio of genetic and molecular testing services organized across three main categories: Pre-Conception services (ora™ Test, CarrierGene™, HPV HR14, STI-7), Pre-Natal services (iGene® NIPT, SingGene NIPT, Fetal DNA Chip, Fetal Seq, Fetal Exome), and Women's Health including Immunology and Serology (Preeclampsia Screening/PlGF). The laboratory serves medical professionals and patients across the South East Asian Region and beyond.
Differentiator
Problem solved
Functional benefit
Brands
- ora™ Test: Pre-conception genetic testing service
- CarrierGene™
- iGene® NIPT
- SingGene NIPT
- Fetal DNA Chip
- Fetal Seq
- Fetal Exome
Products and services
- ora™ Test Pre-conception genetic testing service for reproductive health assessment, available to clinicians and patients.
- CarrierGene™ Carrier screening test for identifying genetic mutations that could be passed to offspring.
- HPV HR14 High-risk Human Papillomavirus test detecting 14 HPV types (16/18/31/33/35/39/45/51/52/56/58/59/66/68) using mRNA technology for cervical cancer screening.
- STI-7 Sexually transmitted infection panel screening for up to six infections (BV, TV, gonorrhea, chlamydia, C. species and C. glabrata) from a single vaginal swab.
- iGene® NIPT Non-Invasive Prenatal Testing service for fetal health assessment.
- SingGene NIPT Singapore-specific Non-Invasive Prenatal Testing service.
- Fetal DNA Chip (version 2.0) Prenatal genetic test analyzing fetal DNA for chromosomal abnormalities.
- Fetal Seq (version 1.0) Fetal DNA sequencing service for genetic analysis.
- Fetal Exome Fetal exome sequencing analyzing protein-coding regions of over 20,000 annotated genes for pathogenic or likely pathogenic variants, with turnaround times of 14 calendar days for trio and 28 calendar days for proband-only analysis.
- Preeclampsia Screening (PlGF) Placenta Growth Factor (PlGF) measurement combined with Uterine Artery Doppler Assessment for preeclampsia risk assessment during pregnancy.
Companies that use iGene Laboratory
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles2 records
iGene Laboratory technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
iGene Laboratory partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Clinicians & DistributorscorePartnerships with clinicians and distributors to diagnose and conduct risk assessment for certain genetic diseases. Partners receive comprehensive reports to supplement clinical decision making and resources to enrich clinical outcomes of patients.
- Contract Research Organizations (CROs)corePartnerships with Contract Research Organizations to provide clinical research services in the area of clinical molecular testing. CROs can leverage iGene's CAP accredited laboratory capabilities for clinical trial support.
Scale indicators2 records
Recent moves6 records
Expansion highlights5 records
iGene Laboratory competitors and assessment
Company assessmentBroad incumbents
- Myriad Genetics: US-based genetic testing leader historically focused on hereditary cancer (BRACAnalysis) and reproductive health (Foresight carrier screen, Prequel NIPT). Comparable product categories in reproductive genetics but materially larger, US-anchored, and a global incumbent versus iGene's regional scope.
- Eurofins Genomics: Division of Eurofins Scientific, one of the world's largest testing services groups, offering genomic services, molecular diagnostics, and clinical trial support. Comparable on CRO-style clinical molecular testing, NGS capability, and global lab services; however, a far broader portfolio and vastly larger scale.
- GeneDx (Sema4): US-based clinical genomics company offering exome sequencing, whole genome sequencing, and rare disease diagnostics, with reproductive health offerings. Comparable on exome-based fetal diagnostics (similar to iGene's Fetal Exome product) and on clinical reporting infrastructure, but operates at national/US scale.
- Sonic Healthcare: Global medical diagnostics provider operating extensive laboratory networks across Australia, Europe, and the US, with growing Asia exposure. Comparable on clinical lab services and molecular diagnostics, including reproductive health; functions as a broad incumbent rather than a focused NIPT specialist.
- Revvity (formerly PerkinElmer): Global life sciences and diagnostics company that operated PerkinElmer Genomics (Vanadis NIPT platform) and supplies reproductive health screening reagents. Comparable on the NIPT/reproductive health value chain (assays, reagents, and software), though it operates upstream and at much greater scale.
- BGI Genomics: One of the world's largest genomics organizations, BGI Genomics offers NIPT, reproductive health, and molecular diagnostics globally, with strong presence across Asia. Directly comparable to iGene on product categories (NIPT, carrier screening, prenatal testing) and competes in the same SEA customer base, but at materially larger scale and broader scope.
Direct peers
- Strand Life Sciences: India-based clinical genomics and molecular diagnostics company offering NIPT, carrier screening, and inherited disease panels. Direct peer in reproductive and clinical genomics, with comparable scale and a similar focus on hospital/clinician channel sales across South and Southeast Asia.
- MedGenome: India- and Singapore-based genetic diagnostics and genomics services company offering NIPT, carrier screening, prenatal diagnostics, and clinical genomics. Most directly comparable peer: similar product mix, comparable scale, overlapping SEA customer base, and similar reliance on NGS-based workflows.
- Novogene: Asia-headquartered (with Singapore presence) genomics services provider offering NGS-based clinical and research services, including rare disease and reproductive health. Comparable to iGene on NGS-based molecular testing capability and SEA footprint, with a stronger research/CRO tilt.
- Natera: US-based leader in cell-free DNA testing with Panorama NIPT and the Vistara single-gene NIPT, plus reproductive and oncology genetics. Direct peer in NIPT and reproductive genetics, although at a much larger scale and global commercial footprint; both compete for the same clinician-driven NIPT adoption dynamics.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks1 record
Key highlights6 records
Customer concentration
iGene Laboratory social profiles
Digital presenceiGene Laboratory compliance and trust
Trust signalCompliance3 records
iGene Laboratory financial estimates
Financial estimateRevenue estimate
Valuation estimate
iGene Laboratory leadership team
Management profileNumber of profiles
iGene Laboratory funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
iGene Laboratory M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about iGene Laboratory
What does iGene Laboratory do?
iGene Laboratory operates a CAP-accredited clinical molecular diagnostics laboratory in Singapore, providing genetic testing, molecular microbiology, immunology, and serology services. Its portfolio covers pre-conception screening (ora™ Test, CarrierGene™), prenatal diagnostics (NIPT, Fetal DNA Chip, Fetal Seq, Fetal Exome), and women's health tests (HPV HR14, STI-7, Preeclampsia/PlGF Screening) for clinicians, clinics, and CROs.
Is iGene Laboratory a public or private company?
iGene Laboratory is a private company. It is classified as corporate owned and is currently operating.
When was iGene Laboratory founded?
iGene Laboratory was founded in 2014. It employs 51 to 100 people.
Where is iGene Laboratory based?
iGene Laboratory is headquartered in Singapore, Singapore, in the Asia region.
How does iGene Laboratory make money?
Two revenue lines are on record. Genetic Testing Services are the primary driver. The others are clinical Research Services (CRO).
Who are iGene Laboratory's main competitors?
Broad incumbents on record are Myriad Genetics, Eurofins Genomics, GeneDx (Sema4), Sonic Healthcare, Revvity (formerly PerkinElmer) and BGI Genomics. Direct peers are Strand Life Sciences, MedGenome, Novogene and Natera.
Does iGene Laboratory have an API?
No public API is recorded for iGene Laboratory.
What industry is iGene Laboratory in?
iGene Laboratory's product category is Clinical Molecular Diagnostics Laboratory Services. Its primary akta.pro industry code is HLAFAMAH, Genetic & Prenatal Testing Laboratories, with a secondary code of HLAAALAJ, Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening). Its NAICS code is 621511 and its SIC code is 8071.